OS Therapies Inc SEC filings OSTX
OS Therapies Inc has 243 filings in SEC EDGAR's recent list, going back to Dec 5, 2019. Its latest annual report, Form ARS, was filed on Jul 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Oct 23, 2026 | — |
| D | Filing | Aug 25, 2026 | — |
| D | Filing | Jul 16, 2026 | — |
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| D | Filing | Mar 6, 2026 | — |
| D | Filing | Jan 20, 2026 | — |
| D | Filing | Sep 10, 2025 | — |
| EFFECT | Filing | Aug 25, 2025 | — |
| CORRESP | Letter to the SEC | Aug 21, 2025 | — |
| NT 10-Q | Notification of late filing | Aug 15, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| D | Filing | Jul 16, 2025 | — |
| EFFECT | Filing | Jun 6, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| UPLOAD | Letter from the SEC | May 28, 2025 | — |
| EFFECT | Filing | Apr 23, 2025 | — |
| EFFECT | Filing | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2025 | — |
| EFFECT | Filing | Feb 13, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| CORRESP | Letter to the SEC | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2025 | — |
| CORRESP | Letter to the SEC | Jan 31, 2025 | — |
| D | Filing | Jan 22, 2025 | — |
| EFFECT | Filing | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| CORRESP | Letter to the SEC | Nov 27, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Jul 31, 2024 | — |
| CERT | Nyse american certification | Jul 30, 2024 | — |
| 8-A12B | For registration of certain classes | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 13, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| RW | Filing | Jun 3, 2024 | — |
| RW | Filing | Jun 3, 2024 | — |
| RW | Withdrawal request | May 30, 2024 | — |
| SP 15D2 | Special financial report | May 20, 2024 | Dec 31, 2023 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Notification of late filing | May 15, 2024 | Dec 31, 2023 |
| SEC STAFF LETTER | Filing | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Jan 24, 2024 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| D | Filing | Dec 14, 2023 | — |
| CORRESP | Letter to the SEC | May 22, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| SEC STAFF LETTER | Filing | Apr 10, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2023 | — |
| DRS/A | Filing | Mar 14, 2023 | — |
| DRSLTR | Filing | Mar 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2023 | — |
| DRSLTR | Filing | Jan 20, 2023 | — |
| DRS/A | Filing | Jan 20, 2023 | — |
| D | Filing | Jan 11, 2023 | — |
| DRS | Filing | Nov 23, 2022 | — |
| D | Filing | Sep 1, 2021 | — |
| D | Filing | May 1, 2020 | — |
| D | Filing | Dec 5, 2019 | — |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OSTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1795091
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.